Peng SY, Tu HF, Yang CC, Wu CH, Liu CJ, Chang KW*,
Lin SC*. miR-134 targets PDCD7 to reduce E-cadherin expression and
enhance oral cancer progression. INTERNATIONAL JOURNAL OF CANCER
2018; In press. (Impact factor: 7.360; Rank: 10.36%)
Yang CC, Chang KW* Eicosanoids and HB-EGF/EGFR in cancer. CANCER METASTASIS REVIEW 2018; In press. (Impact factor: 6.081;
Chou CH, Tu HF, Kao
SY, Fan Chiang C-Y, Liu CJ, Chang KW*, Lin SC*. Targeting of
miR-31/96/182 to the Numb gene during head and neck oncogenesis. HEAD
& NECK 2018; 40(4):808-817. (Impact factor: 3.376;Rank: 2.38%)
Lee LT, Wong YK,
Hsiao HY, Wang YW, Chan MY*, Chang KW*. Evaluation of saliva and
plasma cytokine biomarkers in patients with oral squamous cell carcinoma.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY 2018;
Wang MC, Yeh LY,
Shih WY, Li WC, Chang KW*, Lin SC*. Portland cement induces human
periodontal ligament cells to differentiate by upregulating miR-146a. J
Formosa Medical Association 2018; 117(4):308-315.
Yu EH, Tu HF, Wu
CH, Yang CC, Chang KW*. MicroRNA-21 promotes perineural invasion
and impacts survival in patients with oral carcinoma. Journal of
Chinese Medical Association 2017; 80:383-8.
Lin SC, Kao SY,
Chang J CY, Liu YJ, Yu EH, Tseng SH, Liu CJ*, Chang KW*.
Up-regulation of miR-187 modulates the advances of oral carcinoma by
targeting BARX2 tumor suppressor. Oncotarget 2016; 7(38):61355-65.
Lu WC, Liu CJ, Tu
HF, Chung YT, Yang CC, Kao SY, Chang KW*, Lin SC*. miR-31 targets
ARID1A and enhances the oncogenicity and stemness of head and neck
squamous cell carcinoma. Oncotarget 2016; 7(35):57254-67.
Chen IF, Yang CC,
Kao SY, Liu CJ, Lin SC*, Chang KW*. MicroRNA-211 enhances the
oncogenicity of carcinogen-induced oral carcinoma by repressing TCF12 and
increasing antioxidant activity. CANCER RESEARCH 2016;
76(6):4872-86. (Impact factor: 9.122;Rank: 6.68%)
CC, Tu HF, Wu CC, Chang HC, Chiang WF, Shih NC, Lee YS, Kao SY*, Chang
KW*. Up-regulation of HB-EGF by the COX-2/PGE2 signaling associates
with the cisplatin resistance and tumor recurrence of advanced HNSCC. ORAL
ONCOLOGY 2016; 56:54-61. (Impact factor: 4.794;Rank: 0.56%)
SY, Tsai MM, Wu CH, Chen JJ, Tseng SH, Lin SC*, Chang KW*.
Co-targeting of multiple microRNAs on factor-inhibiting hypoxia-inducible
factor (FIH) gene for the pathogenesis of head and neck carcinomas. HEAD
AND NECK 2016; 38(4):522-8 (Impact factor: 3.376;Rank: 2.38%).
YY, Tu HF, Kao SY, Chang KW*, Lin SC*. The increase of oncogenic miRNA
expression in tongue carcinogenesis of a mouse model. ORAL ONCOLOGY
2015; 51:1103-12. (Impact factor: 4.794;Rank: 0.56%).
SH, Yang CC, Yu EH, Chang C, Lee YS, Liu CJ, Chang KW*, Lin SC*.
K14-EGFP-miR-31 transgenic mice have high susceptibility to
chemical-induced squamous cell tumorigenesis that is associating with
Ku80 repression. INTERNATIONAL JOURNAL OF CANCER 2015;
136(6):1263-75. (Impact factor: 6.513;Rank: 10.83%)
LY, Liu CJ, Wong YK, Chang C, Lin SC*, Chang KW*. miR-372 inhibits
p62 in head and neck squamous cell carcinoma in vitro and in vivo. Oncotarget
WC, Lee PL, Chou IC, Chang WJ, Lin SC, Chang KW*. Molecular and
cellular cues of diet associated oral carcinogenesis – with an
emphasis on areca nut induced oral cancer development. JOURNAL OF ORAL
PATHOLOGY & MEDICINE 2015; 44(3):167-77.
WC, Kao SY, Yang CC, Tu HF, Wu CH, Chang KW*, Lin SC*. EGF
up-regulates miR-31 through the C/EBPβ signal
cascade in oral carcinoma. PLoS One 2014; 9(9):e108049.
EH, Lui MT, Tu HF, Wu CH, Lo WL, Chang KW*, Kao SY*. Oral
carcinoma with perineural invasion has higher nerve growth factor
expression and worse prognosis. Oral Diseases 2014; 20(3):268-74.
CJ, Shen WG, Peng SY, Chang HW, Kao SY, Lin SC, Chang KW*. miR-134
induces oncogenicity and metastasis in head and neck carcinoma through
targeting WWOX gene. INTERNATIONAL JOURNAL OF CANCER 2014;
134(4):811-21 (Impact factor: 6.513;Rank: 10.83%).
PS, Tu HF, Kao SY, Yang CC, Liu CJ, Huang TY, Chang KW*, Lin SC*.
miR-31 is up-regulated in oral premalignant epithelium and contributes to
the immortalization of normal oral keratinocytes. CARCINOGENESIS
2014; 35(5):1162-71 (Impact factor: 5.105;Rank: 20.97%).
TH, Yang CC, Liu CJ, Lui MT, Lin SC*, Chang KW*. miR-211 promotes the
progression of head and neck carcinomas by targeting TGFβRII. Cancer
Letters 2013; 337(1):115-24. (Impact factor: 6.375;Rank: 11.29%).
KW, Kao SY, Wu YH, Tsai MM, Tu HF, Liu
CJ, Lui MT, Lin SC*. Passenger strand miRNA miR-31* regulates the
phenotypes of oral cancer cells by targeting RhoA. Oral Oncology
2013; 49(1):27-33. (Impact factor: 4.794;Rank: 0.56%).
KW, Chu TH, Gong NR, Chiang WF, Yang
CC, Liu CJ, Wu CC, Lin SC*. miR-370 modulates insulin receptor
substrate-1 expression and inhibits the tumor phenotypes of oral
carcinoma. Oral Diseases 2013; 19(6):611-9 .
HF, Liu CJ, Chang CJ, Wang PW, Kao SY, Yang CC, Yu EH, Lin SC*, Chang
KW*. The association between genetic polymorphism and the processing
efficiency of miR-149 affects the prognosis of patients with head and
neck squamous cell carcinoma. PLoS One 2012; 7(e51606):1-10.
HF, Lin SC, Chang KW*. MicroRNA aberrances in head and neck cancer
- pathogenetic and clinical significance. Current Opinion in Otolaryngology
and Head & Neck Surgery 2012; 21:104-11.
CJ, Lin SC, Yang CC, Cheng HW, Chang KW*. Exploiting salivary
miR-31 as a clinical biomarker of oral squamous cell carcinoma. HEAD
AND NECK 2012; 34(2):219-24.
(Impact factor: 3.376;Rank: 2.38%).
MC, Hung PS, Tu HF, Shih WY, Li WC, Chang KW*. Lipopolysaccharide
induces the migration of human dental pulp cells by up-regulating
miR-146a. Journal of Endodontics 2012; 38(12):1598-1603.